First Tranche Closing (50%) of Botanico Transaction Expands International Platform with Exclusive Access to U.S. Genetics, Premium Brands and Advanced AI-Driven Technologies; Company Reports Growing Demand in Germany and Evaluates Opportunities in Regulated U.S. Medical Cannabis Markets. NEW YORK and HERZLIYA, Israel, June 15, 2026 (GLOBE NEWSWIRE) — InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) today announced the successful completion of the first tranche of its acquisition of Botanico Ltd. (“Botanico”), also known as ISHI, an Israeli cannabis technology and brand company. Following the recent U.S. federal rescheduling of certain state-licensed medical cannabis from Schedule I to Schedule III, InterCure has initiated a strategic review of potential opportunities within regulated U.S. medical cannabis...

FORT LAWN, SC, June 15, 2026 (GLOBE NEWSWIRE) — Northann Corp. (“Northann” or the “Company”) (NYSE American: NCL), a flooring and wall panel technology company specializing in advanced 3D printing and digital embossing manufacturing, today announced that it has received formal notice from NYSE American LLC (the “NYSE American”) confirming that the Company has regained compliance with all continued listing standards set forth in Part 10 of the NYSE American Company Guide (the “Company Guide”). In its letter dated June 10, 2026, NYSE American advised the Company that it has resolved the previously disclosed continued listing deficiency relating to the stockholders’ equity requirement under Section 1003(a)(i) of the Company Guide, which had been referenced in the Exchange’s letters dated December 8, 2025. The Company regained compliance...

WESTLAKE, Texas, June 15, 2026 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD), a rapidly growing, independent personal lines insurance agency, today announced the appointment of Eben Hewitt as Chief Technology Officer. Hewitt joins Goosehead from Hyatt Corporation, where he served as Global Chief Information Officer, overseeing engineering, data and AI, infrastructure, cybersecurity, technology operations, and enterprise applications. Prior to Hyatt, he held senior technology leadership positions at Sabre Hospitality Solutions, Choice Hotels, and O’Reilly Media. Throughout his career, Hewitt has built and scaled global technology organizations and developed award-winning software products serving millions of users. As CTO, Hewitt will lead Goosehead’s technology strategy,...

The Board of UAB “Ignitis”, a subsidiary directly controlled by Ignitis Group, a leading integrated energy group in the Baltic region (hereinafter – the Group), has approved the candidacy of Andrius Kavaliauskas for the position of CEO of UAB “Ignitis”. Andrius Kavaliauskas, the current Head of B2C at the company, will replace the company’s CEO Artūras Bortkevičius, whose term of office expires on 9 July 2026. The final decision on the appointment of Andrius Kavaliauskas to the position of CEO of UAB “Ignitis” is planned to be made by 9 July 2026, following the completion of the mandatory impeccable reputation verification procedure. “First, I would like to sincerely thank Artūras Bortkevičius for ensuring stable and efficient activities both in implementing ambitious development goals and in responding to various external challenges....

The Board of UAB “Ignitis”, a subsidiary directly controlled by Ignitis Group, a leading integrated energy group in the Baltic region (hereinafter – the Group), has approved the candidacy of Andrius Kavaliauskas for the position of CEO of UAB “Ignitis”. Andrius Kavaliauskas, the current Head of B2C at the company, will replace the company’s CEO Artūras Bortkevičius, whose term of office expires on 9 July 2026. The final decision on the appointment of Andrius Kavaliauskas to the position of CEO of UAB “Ignitis” is planned to be made by 9 July 2026, following the completion of the mandatory impeccable reputation verification procedure. “First, I would like to sincerely thank Artūras Bortkevičius for ensuring stable and efficient activities both in implementing ambitious development goals and in responding to various external challenges....

Wix Partners with Microsoft 365 Copilot to Bring Website Creation into the Flow of WorkUsers can now generate Wix Harmony websites directly within Microsoft 365 Copilot without context switchingUsers can now generate Wix Harmony websites directly within Microsoft 365 Copilot without context switching NEW YORK – Wix (Nasdaq: WIX) Wix today announced its collaboration with Microsoft to bring Wix Harmony website creation into Microsoft 365 Copilot.  Anyone can now create and access Wix Harmony directly via Copilot’s generally available support for the Open AI Apps SDK, meeting users where they’re already working. The integration also gives access to the entire Wix ecosystem to enable entrepreneurs and businesses to not only launch a digital presence but also manage business logic and analyze performance directly within...

SAN DIEGO, June 15, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the financial advisors of Fortress Financial Planning have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. Advisors Bassem Moez, CRPC® and James Darden, JD, reported serving approximately $150 million in advisory, brokerage and retirement plan assets* and join LPL from MassMutual. Based in the Detroit metro area, Fortress Financial Planning serves a diverse client base that includes pre-retirees, retirees and professionals such as physicians and business owners. The team is focused on delivering personalized financial guidance designed to help clients make informed, confident decisions about their financial future. Fortress Financial Planning is built on a philosophy of independent advice, transparency and education....

Agreement supports pre-production funding for the NVRO Metals Hub and a pathway to market for copper, cobalt and nickel production. VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) — NVRO Metals Limited (TSXV: NVRO | OTCQB: ESGLF | FSE: YGK) (“NVRO Metals” or the “Company”), a clean technology company focused on the recovery of precious and critical metals from sulfidic ores, concentrates, mine waste and tailings, is pleased to announce that it has entered into a Heads of Agreement dated June 10, 2026 (the “Agreement”) with Transamine SA (“Transamine”) for a proposed copper cathode offtake and financing package of up to US$25 million to support the staged launch of the NVRO Metals Hub in the Northern Territory, Australia. The Agreement represents an important milestone in advancing the NVRO Metals Hub toward production...

The Company will showcase its hardware-agnostic neural input ecosystem including Mudra Pro and Mudra Studio, and live neural input demonstrations for AI, XR and robotics  YOKNEAM ILLIT, ISRAEL, June 15, 2026 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (Wearable Devices or the Company), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, today announced its comprehensive lineup for the Augmented World Expo 2026 (AWE 2026). The premier industry conference is set to take place June 15 to 18, 2026, in Long Beach, California, At Booth 648 on the expo floor and in meeting room Hall 201A. As spatial computing and AI agents converge, Wearable Devices is positioning its proprietary neural-input technology as a leading solution for intent-based interfaces. Unlike legacy camera-based motion...

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as an oral presentation at ENDO 2026 Single tablet EB613 achieved a comparable PK/PD profile to Forteo® and multi-tablet EB613, which was evaluated in Entera’s Phase 2 study in postmenopausal women with osteoporosis and low bone mass This major scientific achievement supports advancing single tablet EB613 into Entera’s planned Phase 3 study of EB613 in postmenopausal women with osteoporosis TEL AVIV, June 15, 2026 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today reported comparative Phase 1 data evaluating single-tablet and multi-tablet oral EB613 with Forteo® (teriparatide SC injection, Eli Lilly). The oral...